Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine

Recombinant hemagglutinin-neuraminidase (HN) based subunit vaccine, which is non-infectious and can be produced using insect cell-culture systems, is a potential alternative to conventional live and inactivated Newcastle disease (ND) vaccines. However, process development for manufacture and efficac...

Full description

Bibliographic Details
Main Author: Lye, Ping Ying
Format: Thesis
Language:English
Published: 2020
Subjects:
Online Access:http://eprints.usm.my/52168/
http://eprints.usm.my/52168/1/LYE%20PING%20YING%20-%20TESIS%20cut.pdf
_version_ 1848882183709655040
author Lye, Ping Ying
author_facet Lye, Ping Ying
author_sort Lye, Ping Ying
building USM Institutional Repository
collection Online Access
description Recombinant hemagglutinin-neuraminidase (HN) based subunit vaccine, which is non-infectious and can be produced using insect cell-culture systems, is a potential alternative to conventional live and inactivated Newcastle disease (ND) vaccines. However, process development for manufacture and efficacy assessment of HN based subunit vaccines has been hampered by the absence of reference standards, a cornerstone for robust and sensitive quantitative analytical methods. In this work, a downstream purification strategy was developed to obtain NDV HN which was expressed with a hexa-histidine fusion tag (rHN) to facilitate detection using generic antibodies. Highly purified rHN (~95%) attained after detergent extraction and two-stage ion-exchange-hydroxyapatite column chromatography was subsequently utilized as reference standards for quantitative ELISA development. The calibration curve for the developed ELISA was found to be linear between the range of 15.6‒1000 ng mL−1. The intra- and inter-assay precision expressed as a coefficient of variation (CV) were less than 10% and 12% respectively. Recovery of rHN at different stages of purification was monitored. Quantitation of rHN from crude cell lysates was subsequently performed for dose-ranging antibody response and protective efficacy studies. A higher dose (1500 ng) of rHN was correlated to a significant reduction in virus shedding and attainment of herd immunity, as indicated by a higher proportion of chickens (92%) with hemagglutination inhibition (HI) antibody titers ≥log23.
first_indexed 2025-11-15T18:30:52Z
format Thesis
id usm-52168
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:30:52Z
publishDate 2020
recordtype eprints
repository_type Digital Repository
spelling usm-521682022-04-04T08:32:19Z http://eprints.usm.my/52168/ Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine Lye, Ping Ying R5-920 Medicine (General) Recombinant hemagglutinin-neuraminidase (HN) based subunit vaccine, which is non-infectious and can be produced using insect cell-culture systems, is a potential alternative to conventional live and inactivated Newcastle disease (ND) vaccines. However, process development for manufacture and efficacy assessment of HN based subunit vaccines has been hampered by the absence of reference standards, a cornerstone for robust and sensitive quantitative analytical methods. In this work, a downstream purification strategy was developed to obtain NDV HN which was expressed with a hexa-histidine fusion tag (rHN) to facilitate detection using generic antibodies. Highly purified rHN (~95%) attained after detergent extraction and two-stage ion-exchange-hydroxyapatite column chromatography was subsequently utilized as reference standards for quantitative ELISA development. The calibration curve for the developed ELISA was found to be linear between the range of 15.6‒1000 ng mL−1. The intra- and inter-assay precision expressed as a coefficient of variation (CV) were less than 10% and 12% respectively. Recovery of rHN at different stages of purification was monitored. Quantitation of rHN from crude cell lysates was subsequently performed for dose-ranging antibody response and protective efficacy studies. A higher dose (1500 ng) of rHN was correlated to a significant reduction in virus shedding and attainment of herd immunity, as indicated by a higher proportion of chickens (92%) with hemagglutination inhibition (HI) antibody titers ≥log23. 2020-05 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/52168/1/LYE%20PING%20YING%20-%20TESIS%20cut.pdf Lye, Ping Ying (2020) Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine. Masters thesis, Universiti Sains Malaysia.
spellingShingle R5-920 Medicine (General)
Lye, Ping Ying
Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title_full Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title_fullStr Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title_full_unstemmed Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title_short Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
title_sort expression, purification and quantitation of hemagglutinin-neuraminidase for dose-ranging assessment of a recombinant protein-based newcastle disease subunit vaccine
topic R5-920 Medicine (General)
url http://eprints.usm.my/52168/
http://eprints.usm.my/52168/1/LYE%20PING%20YING%20-%20TESIS%20cut.pdf